BGNE

BeiGene, Ltd. $257.47 1M +14.4% 3M +24.9% YTD +39.9% as of 2025-03-04
+Watchlist
This price data has stopped updating. The last bar is 2025-03-04, 559 days ago — our data source no longer publishes BGNE. Everything below is as of that date, not today.

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.6%
Next 1 week
+0.3%
Next 1 month
-0.3%
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -1.3% median, 50% of the last 8 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 50
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.13%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.47 -0.1% · Seasonal tilt (8y) -0.2%
$27.4B market cap (#510 US) $147M/day volume 43% volatility +55% 1-year -40% from ATH
52-week range · 81% of the way up · -11% from the high
$126.97$287.88

Congressional trades in BGNE Full tracker →

3 members · 1 buys / 3 sells · $4K–$60K disclosed · latest filing Aug 13, 2023.

SELL DG Daniel Goldman · traded Jul 10, 2023 $1K–$15K
SELL DG Daniel Goldman · traded Jul 12, 2023 $1K–$15K
BUY GG Greg Gianforte · traded Nov 13, 2020 $1K–$15K
SELL MS Mikie Sherrill · traded May 28, 2019 $1K–$15K

Earnings Full history →

No scheduled report date yet.

1-day std dev
4.5%
Finished up
33%
Biggest pop
+12.6%
Biggest drop
-8.1%

Standard deviation of the close-to-close move over the last 36 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.